Theriva Biologics Inc (TOVX)

[Seel]

This is 8k info re MRI - (g) the complete analysis (the “MRI Analysis”) of a third party specified by Company, which Institution has no reasonable and significant objection (based solely on the fact the retention of the third party consultant would violate any law, regulation, ruling of a court or agency, contractual agreement, or written Institution policy) that is hired as a consultant by Institution and as part of its research team, and which consultant will have full access to all the MRI data resulting from the Study, including a copy of the electronic database containing such images, and will conduct the analysis as generally specified by Company,MRI data being made available not later than August 1, 2015 (costs of the third party consultant will be paid by Company);
(h) complete copy of the actual analysis of the MRI data resulting from the Study existing as of the CTA Amendment effective date, provided to Company by July 10, 2015

So - date of receipt for MRI data and UCal analysis is July 10. Then Aug 1st is next date given for MRI data 'made available'. UCal and consultant have until Aug1 to finish up and hand data to SYN subsidiary. So - this falls within the 30day window given. UC analysis delivered July 10. Full data package with consultants analysis by Aug 1.
DrV already submitted her draft to Syn in June. Publishing at her level - elite grouping of just a few dozen fieldleaders worldwide, can be slow. SYN has no restrictions on sharing data and analysis with affiliates/sublicensees and potential development partners regardless of her date of publication. That's much more important than them going public. As long as they can bargain with potential development partners, we're moving forward. After Aug 1st, they can.